Anti-angiogenesis: Opening a new window for immunotherapy

Area of Science:

• Oncology
• Cancer Research
• Immunology

Background:

• The tumor microenvironment (TME) is crucial for solid tumor survival and development.
• Tumor angiogenesis and the tumor immune microenvironment are key TME research areas.
• Antiangiogenic therapy and immunotherapy are significant cancer treatment strategies.

Purpose of the Study:

• To analyze the mechanisms underlying the combination of immunotherapy and antiangiogenic therapy.
• To discuss recent clinical trial progress for this combined treatment approach.
• To identify challenges and provide insights for effective clinical application.

Main Methods:

• Literature review of studies on TME, angiogenesis, and immunotherapy.
• Analysis of preclinical and clinical data on combined treatment strategies.
• Evaluation of regulatory interactions between antiangiogenic therapy and immunotherapy.

Main Results:

• Complex regulatory interactions exist between immunotherapy and antiangiogenic therapy.
• Combination strategies have shown positive results in various tumor types.
• Despite successes, significant challenges remain in clinical application.

Conclusions:

• The combination of immunotherapy and antiangiogenic therapy offers a promising approach for cancer treatment.
• Understanding the intricate mechanisms and addressing current challenges is vital for optimizing clinical outcomes.
• Further research and clinical trials are needed to fully realize the potential of this combination therapy.